Article

Phenotypic changes of morphologically identified guinea-pig myenteric neurons following intestinal inflammation.

Department of Anatomy and Cell Bioology, University of Melbourne, Parkville, Victoria 3010, Australia.
The Journal of Physiology (Impact Factor: 4.54). 10/2007; 583(Pt 2):593-609. DOI: 10.1113/jphysiol.2007.135947
Source: PubMed

ABSTRACT We investigated the responses of morphologically identified myenteric neurons of the guinea-pig ileum to inflammation that was induced by the intraluminal injection of trinitrobenzene sulphonate, 6 or 7 days previously. Electrophysiological properties were examined with intracellular microelectrodes using in vitro preparations from the inflamed or control ileum. The neurons were injected with marker dyes during recording and later they were recovered for morphological examination. A proportion of neurons with Dogiel type I morphology, 45% (32/71), from the inflamed ileum had a changed phenotype. These neurons exhibited an action potential with a tetrodotoxin-resistant component, and a prolonged after-hyperpolarizing potential followed the action potential. Of the other 39 Dogiel type I neurons, no changes were observed in 36 and 3 had increased excitability. The afterhyperpolarizing potential (AHP) in Dogiel type I neurons was blocked by the intermediate conductance, Ca(2+)-dependent K(+) channel blocker TRAM-34. Neurons which showed these phenotypic changes had anally directed axonal projections. Neither a tetrodotoxin-resistant action potential nor an AHP was seen in Dogiel type I neurons from control preparations. Dogiel type II neurons retained their distinguishing AH phenotype, including an inflection on the falling phase of the action potential, an AHP and, in over 90% of neurons, an absence of fast excitatory transmission. However, they became hyperexcitable and exhibited anodal break action potentials, which, unlike control Dogiel type II neurons, were not all blocked by the h current (I(h)) antagonist Cs(+). It is concluded that inflammation selectively affects different classes of myenteric neurons and causes specific changes in their electrophysiological properties.

0 Followers
 · 
91 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Effective colonic motility involves an intricate pattern of excitatory and inhibitory neuromuscular signals that arise from the enteric neural circuitry of the colon. Recent investigations have demonstrated that inflammation leads to a variety of changes in the physiological properties of the neurons in this circuitry, including hyperexcitability of neurons at the afferent end of the peristaltic reflex, synaptic facilitation, and attenuated inhibitory neuromuscular transmission. Furthermore, links have been established between these changes and disrupted motor activity in the colon, and we now know that some of these changes persist long after recovery from inflammation. It is highly likely that inflammation-induced neuroplasticity, which is not detectable by clinical diagnostics, contributes to disrupted motility in active and quiescent inflammatory bowel disease and in functional gastrointestinal disorders.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background & Aims: Damage to the enteric nervous system (ENS) associated with intestinal inflammation may underlie persistent alterations to gut functions, suggesting that enteric neurons are viable targets for novel therapies. Mesenchymal stem cells (MSCs) offer therapeutic benefits for attenuation of neurodegenerative diseases by homing to areas of inflammation and exhibiting neuroprotective, anti-inflammatory, and immunomodulatory properties. In culture, MSCs release soluble bioactive factors promoting neuronal survival and suppressing inflammation suggesting that MSC-conditioned medium (CM) provides essential factors to repair damaged tissues. We investigated whether MSC and CM treatments administered by enema attenuate 2, 4, 6-trinitrobenzene-sulfonic acid (TNBS)-induced enteric neuropathy and motility dysfunction in the guinea-pig colon. Methods: Guinea-pigs were randomly assigned to experimental groups and received a single application of TNBS (30mg/kg) followed by 1x10(6) human bone marrow-derived MSCs, 300µL CM, or 300µL unconditioned medium (UCM) 3 hours later. After 7 days, the effect of these treatments on enteric neurons was assessed by histological, immunohistochemical, and motility analyses. Results: MSC and CM treatments prevented inflammation-associated weight loss and gross morphological damage in the colon, decreased the quantity of immune infiltrate in the colonic wall (P<.01) and at the level of the myenteric ganglia (P<.001), prevented loss of myenteric neurons (P<.05) and damage to nerve processes, changes in ChAT and nNOS immunoreactivity (P<.05), and alleviated inflammation-induced colonic dysmotility (contraction speed; P<.001, contractions/min; P<.05). Conclusion: These results provide strong evidence that both MSC and CM-treatments can effectively prevent damage to the ENS and alleviate gut dysfunction caused by TNBS-induced colitis.
    AJP Gastrointestinal and Liver Physiology 10/2014; DOI:10.1152/ajpgi.00174.2014 · 3.74 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Disorders of gastrointestinal functions that are controlled by enteric neurons commonly accompany fatty liver disease. Established fatty liver disease is associated with diabetes, which itself induces enteric neuron damage. Here, we investigate the relationship between fatty liver disease and enteric neuropathy, in animals fed a high-fat, high-cholesterol diet in the absence of diabetes.
    Neurogastroenterology and Motility 06/2014; DOI:10.1111/nmo.12385 · 3.42 Impact Factor

Preview

Download
0 Downloads
Available from